Sign in

NCT03066596Completed

Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination

Source: ClinicalTrials.gov · Last updated 21 Oct 2025

Brief summary (registry, in English)

The overall goal of this research study is to test the effectiveness of a multifaceted and multi-level prompting intervention in a real world urban primary care office setting on improving provider-delivered guideline-based asthma care and reducing asthma morbidity among urban children with persistent or uncontrolled asthma.

Status (registry)
Completed
Study type
Interventional
Enrollment
530 (actual)
First submitted
16 Feb 2017
Start date
7 Mar 2017
Primary completion date
24 Aug 2024
Lead sponsor
Montefiore Medical Center
Diseases
Asthma
NCT number
NCT03066596

What you commit to

  • Study type: Interventional
  • Participants enrolled: 530
  • From 7 Mar 2017 to the primary completion date, 24 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The child has other significant medical conditions, such as congenital heart disease, cystic fibrosis, or other chronic lung disease, that could interfere with the assessment of asthma-related measures
    • Additional exclusion criteria will apply to a subset of 512 children/caregivers as described above:

Other

  • No access to a telephone to conduct follow-up surveys
  • Children in foster care or other situations in which consent cannot be obtained from a guardian

Who the study is looking for

  • The criteria listed below will apply to \~5,000 children from eMPI and eUC practices:
  • Physician-diagnosed asthma (based on EHR)
  • Persistent or uncontrolled asthma as per clinic assessment. Based on NHLBI guidelines, any one of the following: in past month, \> 2 days/week with asthma symptoms, \>2 days/week with rescue medication use, \>2 days/month with nighttime symptoms, or \> 2 episodes in the past year that required systemic corticosteroids
  • Age 2 and 12 years, inclusive
    • Additional inclusion criteria will apply to a subset of 512 of children whose caregivers will be interviewed to obtain caregiver-reported morbidity outcomes:
  • Caregiver is able to speak and understand either English or Spanish. Participants unable to read will be eligible as all surveys will be administered verbally by research personnel
  • Consent from the primary caregiver, caregiver permission for the child to participate as well as assent from the child (\>7 years). If there are eligible siblings, only one child will be randomly selected

Age in the registry: 2 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Hospital at Montefiore, Albert Einstein College of Medicine
Coordinator of this site? Confirm its status
The BronxUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.